Pfizer Bridge Program: Genotropin

Funded

About

The Pfizer Bridge Program: Genotropin offers an excellent opportunity for patients prescribed Genotropin and Genotropin Miniquick to receive their medication at no cost for up to three months while waiting for insurance reauthorization or appeals outcomes. This program is designed to support eligible patients, ensuring they continue their treatment without interruptions. The Pfizer Bridge Program makes access to Genotropin easier and more affordable, enhancing patient security and convenience.

Insurance requirements: Commercially insured, Underinsured

Enrollment Forms

Enrollment Form

Program Requirements

•Valid only for residents in the US and Puerto Rico

•Enrollment Required: Yes

•Coverage Required: No

•Needs Based: No

•Activation Required: No

Program Details

•Eligible, commercially insured patients may be able to receive medication at no cost for up to three months while they await reauthorization or appeals outcome

•Interim care support duration is for a maximum of 90 days. Requests for assistance beyond 90 days are evaluated on a casebycase basis

•HCP and patient should complete the Pfizer Bridge Program Enrollment Form and fax to 8004792562

•For assistance or additional information, call 18006451280, Monday – Friday, 9 am–7 pm ET

Enrollment Forms

Enrollment Form